CoChat

Cell senescence in neuropathology: A focus on neurodegeneration and tumours

Open access
Carreno, Gabriela, Guiho, Romain, Martinez‐Barbera, Juan Pedro · 2021 · Neuropathology and Applied Neurobiology
Cited by 74

The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.

Abstract

The study of cell senescence is a burgeoning field. Senescent cells can modify the cellular microenvironment through the secretion of a plethora of biologically active products referred to as the senescence‐associated secretory phenotype (SASP). The consequences of these paracrine signals can be either beneficial for tissue homeostasis, if senescent cells are properly cleared and SASP activation is transient, or result in organ dysfunction, when senescent cells accumulate within the tissues and SASP activation is persistent. Several studies have provided evidence for the role of senescence and SASP in promoting age‐related diseases or driving organismal ageing. The hype about senescence has been further amplified by the fact that a group of drugs, named senolytics, have been used to successfully ameliorate the burden of age‐related diseases and increase health and life span in mice. Ablation of senescent cells in the brain prevents disease progression and improves cognition in murine models of neurodegenerative conditions. The role of senescence in cancer has been more thoroughly investigated, and it is now accepted that senescence is a double‐edged sword that can paradoxically prevent or promote tumourigenesis in a context‐dependent manner. In addition, senescence induction followed by senolytic treatment is starting to emerge as a novel therapeutic avenue that could improve current anti‐cancer therapies and reduce tumour recurrence. In this review, we discuss recent findings supporting the role of cell senescence in the pathogenesis of neurodegenerative diseases and in brain tumours. A better understanding of senescence is likely to result in the development of novel and efficacious anti‐senescence therapies against these brain pathologies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/nan.12689

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 118 references

Research works printed but not linked: 80

  1. 10.1016/0014-4827(61)90192-6 · DOI · Paper page
  2. 10.1016/0014-4827(65)90211-9 · DOI · Paper page
  3. 10.1016/j.tcb.2018.02.001 · DOI · Paper page
  4. 10.3390/ijms20092158 · DOI · Paper page
  5. 10.1016/j.molmed.2020.03.005 · DOI · Paper page
  6. 10.15252/emmm.201810234 · DOI · Paper page
  7. 10.1007/s00109-018-1686-x · DOI
  8. 10.3233/JPD-191724 · DOI · Paper page
  9. 10.1073/pnas.92.20.9363 · DOI · Paper page
  10. 10.1038/s41556-018-0249-2 · DOI · Paper page
  11. 10.1038/onc.2017.235 · DOI
  12. 10.1016/j.celrep.2016.02.061 · DOI
  13. 10.1073/pnas.211053698 · DOI · Paper page
  14. 10.3389/fncel.2020.00016 · DOI · Paper page
  15. 10.1038/sj.onc.1203895 · DOI
  16. 10.1038/sj.cdd.4401962 · DOI · Paper page
  17. 10.1158/0008-5472.CAN-06-1569 · DOI
  18. 10.1084/jem.20161387 · DOI · Paper page
  19. 10.1016/j.cmet.2019.01.018 · DOI · Paper page
  20. 10.1002/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>3.0.CO;2-P · doi:10.1002/(sici)1097-4547(19990715)57:2<195::aid-jnr5>3.0.co;2-p
  21. 10.1080/10715762.2018.1489128 · DOI
  22. 10.3390/nu12051344 · DOI
  23. 10.1002/1878-0261.12761 · DOI · Paper page
  24. 10.1126/science.aaf6659 · DOI · Paper page
  25. 10.1111/acel.13117 · DOI
  26. 10.1038/s41591-019-0549-5 · DOI · Paper page
  27. 10.1111/bpa.12216 · DOI · Paper page
  28. 10.3389/fnagi.2020.00148 · DOI · Paper page
  29. 10.1101/cshperspect.a006239 · DOI · Paper page
  30. 10.1111/acel.12641 · DOI · Paper page
  31. 10.1186/s13024-017-0207-7 · DOI · Paper page
  32. 10.1186/s13024-015-0035-6 · DOI · Paper page
  33. 10.1136/jnnp-2017-316201 · DOI · Paper page
  34. Cacabelos R, 1994, Brain interleukin‐1beta in Alzheimer’s disease and vascular dementia, Methods Find Exp Clin Pharmacol., 16, 141
  35. 10.1016/j.biopsych.2010.06.012 · DOI · Paper page
  36. 10.1111/j.1365-2990.2012.01306.x · DOI · Paper page
  37. 10.3233/JAD-2011-101014 · DOI · Paper page
  38. 10.1038/s41593-020-0624-8 · DOI · Paper page
  39. Wang WY, 2015, Role of pro‐inflammatory cytokines released from microglia in Alzheimer’s disease, Ann Transl Med., 3, 136
  40. 10.1093/hmg/ddr451 · DOI
  41. 10.7150/thno.19824 · DOI
  42. Ghasemi N, 2017, Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell‐based therapy, Cell J, 19, 1
  43. 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F · DOI · Paper page
  44. 10.1073/pnas.1818348116 · DOI · Paper page
  45. Müller HL, 2019, Craniopharyngioma, Nat Rev Dis Prim., 5, 1
  46. 10.1159/000506904 · DOI · Paper page
  47. 10.1007/s00401-018-1830-2 · DOI · Paper page
  48. 10.1080/23723556.2018.1435180 · DOI
  49. 10.1007/s00401-012-0957-9 · DOI · Paper page
  50. 10.1186/s40478-016-0321-8 · doi:10.1186/s40478-016-0321-8
  51. 10.1073/pnas.1101553108 · DOI · Paper page
  52. Andoniadou CL, 2013, The Sox2 + population of the adult murine pituitary includes progenitor/stem cells with tumour‐inducing potential, Cell Stem Cell, 419
  53. 10.1111/bpa.12501 · DOI
  54. 10.1186/s40478-020-00902-z · DOI · Paper page
  55. 10.1212/01.wnl.0000277271.47601.a1 · DOI
  56. 10.1146/annurev-genet-120417-031642 · DOI
  57. 10.1038/ng.2682 · DOI · Paper page
  58. 10.1158/1078-0432.CCR-11-0127 · DOI · Paper page
  59. 10.1158/1078-0432.CCR-10-0438 · DOI
  60. 10.1158/0008-5472.CAN-09-1851 · DOI · Paper page
  61. 10.1007/s00401-018-1837-8 · DOI · Paper page
  62. 10.1097/NEN.0000000000000188 · DOI · Paper page
  63. 10.1007/s00401-020-02127-9 · DOI · Paper page
  64. 10.3389/fonc.2019.00963 · DOI · Paper page
  65. 10.1158/0008-5472.CAN-18-1733 · DOI · Paper page
  66. 10.3389/fonc.2018.00503 · DOI
  67. 10.3390/ijms20071562 · DOI
  68. 10.18632/oncotarget.26502 · DOI
  69. 10.1016/j.ijrobp.2018.08.033 · DOI
  70. 10.3171/jns.2006.105.1.111 · DOI
  71. 10.1016/j.canlet.2020.06.023 · DOI
  72. 10.1073/pnas.1321014111 · DOI · Paper page
  73. Rahman M, 2020, Selective vulnerability of senescent glioblastoma cells to Bcl‐XL inhibition, bioRxiv
  74. Northcott PA, 2019, Medulloblastoma, Nat Rev Dis Prim., 5, 1
  75. 10.1158/0008-5472.CAN-17-4060 · DOI
  76. 10.1007/s00401-016-1545-1 · DOI · Paper page
  77. 10.1097/PAS.0b013e318294e817 · DOI
  78. Flannery PC, 2018, Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma, Oncol Rep., 39, 455
  79. 10.1016/j.celrep.2020.108286 · DOI
  80. 10.4061/2011/857484 · DOI · Paper page

Cited by

Metadata

Authors
Carreno, G., Guiho, R., & Martinez‐Barbera, J. P.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2021-02
Volume
47
Issue
3
Pages
359-378
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W3116069652
Cited by
74
References
118
FWCI
4.53
Type
journal article
Language
en
Open access
hybrid
Funders
  • Cancer Research UK
  • Children's Cancer and Leukaemia Group
  • CHILDREN with CANCER UK
  • University College London

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.